Form 8-K - Current report:
SEC Accession No. 0001193125-20-196219
Filing Date
2020-07-21
Accepted
2020-07-21 14:39:02
Documents
13
Period of Report
2020-07-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d30777d8k.htm   iXBRL 8-K 24324
2 EX-99.1 d30777dex991.htm EX-99.1 53266
  Complete submission text file 0001193125-20-196219.txt   192502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20200721.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20200721_lab.xml EX-101.LAB 15318
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20200721_pre.xml EX-101.PRE 9661
6 EXTRACTED XBRL INSTANCE DOCUMENT d30777d8k_htm.xml XML 2984
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 201038656
SIC: 2835 In Vitro & In Vivo Diagnostic Substances